Scholarly Index
Takayuki Matsumoto
University of Miyazaki; 14,468 total citations; 609 total publications; best world rank #89
University of Miyazaki
14,468Total citations
609Total publications
59H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Nitric Oxide and Endothelin Effects | Lifetime | 318 | JP 18 | 98.56 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 324 | JP 15 | 97.83 |
| Inflammatory Bowel Disease | Lifetime | 443 | JP 17 | 98.11 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 906 | JP 109 | 97.29 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 185 | JP 17 | 95.64 |
| Autoimmune and Inflammatory Disorders | Lifetime | 337 | JP 14 | 95.32 |
| Renin-Angiotensin System Studies | Lifetime | 504 | JP 57 | 95.66 |
| Advanced Glycation End Products research | Lifetime | 590 | JP 79 | 93.61 |
| Adenosine and Purinergic Signaling | Lifetime | 792 | JP 37 | 93.62 |
| Hypertrophic osteoarthropathy and related conditions | Lifetime | 144 | JP 16 | 70.93 |
| Lymphatic Disorders and Treatments | Lifetime | 998 | JP 128 | 51.50 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 89 | JP 1 | 87.56 |
| Nitric Oxide and Endothelin Effects | 2021-2025 | 211 | JP 4 | 78.45 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 498 | JP 30 | 70.82 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 255 | JP 16 | 63.76 |